Forskning
Udskriv Udskriv
Switch language
Bispebjerg Hospital - en del af Københavns Universitetshospital
Udgivet

Healthcare utilization in Danish children with atopic dermatitis and parental topical corticosteroid phobia

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Family burden of hospital-managed pediatric atopic dermatitis: A nationwide registry-based study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Predictors of atopic disease in children of women with asthma

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  3. The validity of register data to identify children with atopic dermatitis, asthma or allergic rhinoconjunctivitis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Inappropriate reporting of clinical trials

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  1. Family burden of hospital-managed pediatric atopic dermatitis: A nationwide registry-based study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Predictors of Response to Biologics in Patients with Moderate-to-severe Psoriasis: A Danish Nationwide Cohort Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Bariatric surgery and risk of new-onset inflammatory bowel disease: A nationwide cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Global Prevalence of Young-Onset Dementia: A Systematic Review and Meta-analysis

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

Vis graf over relationer

BACKGROUND: Atopic dermatitis (AD) is a prevalent relapsing inflammatory skin disease. There is currently little knowledge about healthcare utilization and medication use along with parental corticosteroid phobia in relation to severity of pediatric AD.

OBJECTIVES: To study the association between parental-reported healthcare utilization, medication use, and topical corticosteroid phobia and pediatric AD severity.

METHODS: The study population included all children in Denmark with a diagnostic code of AD (ICD-10 code, group L20) given at a hospital department of dermatology between 2014 and 2018. A questionnaire containing 158 response items was sent to the legal parents. We surveyed disease severity, AD treatment, corticosteroid phobia, and healthcare use along with other variables. Disease severity was assessed using the Patient-Oriented Eczema Measure tool, and corticosteroid phobia was assessed using the Topical Corticosteroid Phobia (TOPICOP) score.

RESULTS: In total, 1343 (39%) parents completed the questionnaire and 95.3% were completed by the biological mother. Children's mean age was 8.9 ± 4.5 years, and 52.8% were boys. Severe AD was associated with a higher number of healthcare visits to GPs, private dermatologists, and hospital departments. Mean global TOPICOP score was 38.27 ± 19.9%. There was a significant inverse linear trend between global TOPICOP score and parental educational level (Ptrend < .0005).

CONCLUSIONS: The significant association between high global TOPICOP score and low parental educational level, resulting in delayed treatment of AD flares, indicates that improved family education ultimately may reduce healthcare expenses and burden of disease.

OriginalsprogEngelsk
TidsskriftPediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
Vol/bind32
Udgave nummer2
Sider (fra-til)331-341
Antal sider11
ISSN0905-6157
DOI
StatusUdgivet - feb. 2021

Bibliografisk note

© 2020 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.

ID: 69210765